APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.
about
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytesBCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamilyThe apoptosis-1/Fas protein in human systemic lupus erythematosus.Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokinesProtooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiationMorphological and immunophenotypic features of chronic lymphocytic leukemia.Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.Biology of chronic lymphocytic leukemia.Death receptors couple to both cell proliferation and apoptosis.Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicityTargeted therapies in oncology: in the crosshairs or at the crossroads?Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.Receptor-induced death in human natural killer cells: involvement of CD16.Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.Disruption of fas receptor signaling by nitric oxide in eosinophils.Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma.Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cellsOverexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.Fas ligation induces apoptosis of CD40-activated human B lymphocytes.Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells.Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors.Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression.Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95).Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.Apoptosis and inflammation.Transitional B cells are the target of negative selection in the B cell compartment.Prognostic significance of Bcl-2 in clinically localized prostate cancer.Fas ligand mediates activation-induced cell death in human T lymphocytes.TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferation.Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines.Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells
P2860
Q33888184-82E3E52D-CE52-42FB-A7F9-F5D46120B6A7Q33924832-63D638A0-E8EA-4DB3-8E75-E9CEA1EFB63BQ33964729-999A5BDE-44FC-4AAD-A97A-2C978B48C565Q34131476-391C1D70-6A32-45AD-A41A-02CB0CF2C078Q34182237-FE688837-358A-48F4-B42D-1E5F96625270Q34223630-003967C7-009C-4EDC-87E2-892808DA03B1Q34326557-9BB385D3-0106-4C87-BC92-38E8477F3DC9Q34326560-F4818036-0921-4773-8EE0-C422BF279E49Q34329516-2FB39EF7-85C3-4501-ADD8-9FCB44DA620DQ34537833-31219557-14D5-4AF6-860E-D0D90D4B1504Q35326190-7D260D6B-C625-4E20-836A-8F81FD82BA8AQ35641209-123CEF84-73A6-463E-95D8-8E2BB30D00FDQ35774239-BC40392D-3DDD-4C17-A0B0-8956A8B3DE16Q35833999-B963C39A-0F4B-41BE-AF82-947053B93FBBQ36364230-83E5C157-0063-406D-88CF-EE585F0675D3Q36381058-D85E18BF-7066-4395-8C62-16A8B09AE3E9Q36400192-459572B6-571E-4DB0-BEFA-96AF2C8CED10Q36611899-1D5BB066-D700-4620-8078-96A2423C3F0AQ36636274-9A545C0E-8F78-459F-B6EC-B885969D4D0DQ36800905-C9A6DE97-2B2B-43D8-ADA8-E136ABD13783Q39018355-914027B6-A690-48CF-BBC7-8962A3A252E1Q39339749-B1AAC55D-C44C-49A0-8805-F921058B3836Q40657330-348EFF47-A297-4A1E-BB20-1AB7391D630FQ40933974-15E5D5F8-1DCE-4209-8CAB-44E5DB45582DQ40993369-CA0E46D7-79E2-4F17-AE1A-1D9521EA0BB5Q41064231-6700F974-6E02-47F3-AAFD-9CC8B3791D56Q41195420-00DE51A2-1B1F-43FE-8A2B-C75410805F6AQ41489300-10B46B34-3727-4D15-B1EF-871C5AF20D97Q41861701-945EB527-CCCA-4990-8197-E51877B73B36Q41894378-4EB2340A-9D0A-4824-A6D5-4FE9C683F281Q42026939-8ED77E0E-C926-4F1D-AFFE-87C50E448C52Q42118720-53A329F7-9645-4835-BB4D-A372C5C091C7Q42942730-D22B3821-C9BC-4947-AF0A-E42390086C54Q44482351-203E2E2C-6886-4940-9014-BDD6218B655CQ47931842-520D34B8-B147-4743-BA91-65E62CDBADD4Q51071316-67BF5B04-5E40-43F9-9F80-512472BFA26FQ55318669-B7F36904-B472-46FD-B6A9-AC2E819FAB12Q58415191-38D49A85-0E32-4FBD-913A-B92026B487E6
P2860
APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@en
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@nl
type
label
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@en
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@nl
prefLabel
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@en
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@nl
P2093
P356
P1476
APO-1 mediated apoptosis or pr ...... ith bcl-2 oncogene expression.
@en
P2093
Krammer PH
Ustaoglu F
P304
P356
10.1002/EJI.1830230320
P407
P577
1993-03-01T00:00:00Z